Bone Regeneration and Repair
暂无分享,去创建一个
[1] M. Hurley,et al. Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. , 1998, Bone.
[2] G. Hofmann,et al. Allogenic grafting of vascularized bone segments under immunosuppression. Clinical results in the transplantation of femoral diaphyses , 1998, Transplant international : official journal of the European Society for Organ Transplantation.
[3] H. Oxlund,et al. Local injection of TGF-beta increases the strength of tibial fractures in the rat. , 1994, Acta orthopaedica Scandinavica.
[4] J Glowacki,et al. Comparison of multinucleated cells elicited in rats by particulate bone, polyethylene, or polymethylmethacrylate , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] D. Dills,et al. Interaction of insulin-like growth factor I/somatomedin-C with cultured rat chondrocytes: receptor binding and internalization. , 1986, Endocrinology.
[6] R. D. Ray,et al. Bone Grafts: Cellular Survival Versus Induction , 1963 .
[7] J. Schmitt,et al. Bone morphogenetic proteins: An update on basic biology and clinical relevance , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[8] P. Cuevas,et al. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. , 1988, Biochemical and biophysical research communications.
[9] J. Wozney,et al. Transforming growth factor-beta gene family members and bone. , 1994, Endocrine reviews.
[10] T. Andreassen,et al. Increased mechanical strength of healing rat tibial fractures treated with biosynthetic human growth hormone. , 1990, Bone.
[11] I. Weissman,et al. The aging of hematopoietic stem cells , 1996, Nature Medicine.
[12] M. Gebhardt,et al. Current status of allografting for bone tumors. , 1992, Orthopedics.
[13] R. Kitazawa,et al. Expression of platelet-derived growth factor proteins and their receptor alpha and beta mRNAs during fracture healing in the normal mouse. , 1999, Histochemistry and cell biology.
[14] W. Hayes,et al. Failure of growth hormone to alter the biomechanics of fracture-healing in a rabbit model. , 1992, The Journal of bone and joint surgery. American volume.
[15] J. Smith,et al. Fibroblast growth factors and their receptors. , 1997, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[16] S. Stevenson,et al. Enhancement of fracture healing with autogenous and allogeneic bone grafts. , 1998, Clinical orthopaedics and related research.
[17] K. Takagi,et al. The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. , 1982, Clinical orthopaedics and related research.
[18] W. Hutton,et al. Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.
[19] A. Tadmor,et al. The effect of growth hormone on the healing of experimental bone defects. , 1971, Acta orthopaedica Scandinavica.
[20] E. Wang,et al. Long-term healing of bone using recombinant human bone morphogenetic protein 2. , 1995, Clinical orthopaedics and related research.
[21] K. Copeland,et al. Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. , 1980, The Journal of clinical endocrinology and metabolism.
[22] T. Sakou. Bone morphogenetic proteins: from basic studies to clinical approaches. , 1998, Bone.
[23] M. Chapman,et al. Morbidity at bone graft donor sites. , 1989, Journal of orthopaedic trauma.
[24] T. Yamamuro,et al. Heterotopic bone formation induced by bone morphogenetic protein in mice with collagen-induced arthritis. , 1992, Biochemical and biophysical research communications.
[25] J N Beresford,et al. Osteogenic stem cells and the stromal system of bone and marrow. , 1989, Clinical orthopaedics and related research.
[26] S. Cook,et al. In Vivo Evaluation of Recombinant Human Osteogenic Protein (rhOP-1) Implants As a Bone Graft Substitute for Spinal Fusions , 1994, Spine.
[27] A. Freemont,et al. Platelet-derived growth factor expression in normally healing human fractures. , 1995, Bone.
[28] W. Macewen. I. Intrahuman Bone Grafting and Reimplantation of Bone. , 1909, Annals of surgery.
[29] Mark E. Bolander,et al. Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[30] G. Hansson,et al. Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. , 1988, Experimental cell research.
[31] J. Wozney,et al. Clinical evaluation of recombinant human bone morphogenetic protein-2. , 2002, Clinical orthopaedics and related research.
[32] S. Duursma,et al. The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs? , 1990, The Journal of endocrinology.
[33] W. Enneking,et al. Autogenous cortical bone grafts in the reconstruction of segmental skeletal defects. , 1980, The Journal of bone and joint surgery. American volume.
[34] D. E. Ashhurst,et al. Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit. , 1995, Acta orthopaedica Scandinavica.
[35] D. Gospodarowicz,et al. Purification of the fibroblast growth factor activity from bovine brain. , 1978, The Journal of biological chemistry.
[36] N. Ling,et al. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[37] W. Enneking,et al. Short-term immunosuppression with fresh segmental fibular allografts in dogs. , 1981, The Journal of bone and joint surgery. American volume.
[38] E. Blitch,et al. Introduction to bone grafting. , 1996, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.
[39] R. Lorentzon,et al. Treatment of deep cartilage defects of the patella with periosteal transplantation , 1998, Knee Surgery, Sports Traumatology, Arthroscopy.
[40] J. Connolly,et al. Development of an osteogenic bone-marrow preparation. , 1989, The Journal of bone and joint surgery. American volume.
[41] M. Czech. Signal transmission by the insulin-like growth factors , 1989, Cell.
[42] H. Tesluk,et al. The Effects of Insulin-like Growth Factor-1 on Critical-Size Calvarial Defects in Sprague—Dawley Rats , 1993, Annals of plastic surgery.
[43] R. Holmes,et al. Effect of Insulin-like Growth Factor-1 on Zygomatic Arch Bone Regeneration: A Preliminary Histological and Histometric Study , 1993, Annals of plastic surgery.
[44] J. Lian,et al. Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. , 1988, Bone.
[45] R. Hierner,et al. Vascularized bone transfer. , 1994, Injury.
[46] J F Connolly,et al. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. , 1991, Clinical orthopaedics and related research.
[47] V. Rosen,et al. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.
[48] P. Alberius,et al. Autoclaved Bone for Craniofacial Reconstruction: Effects of Supplementation with Bone Marrow or Recombinant Human Fibroblast Growth Factor‐2 , 1998 .
[49] M. Wood,et al. A biomechanical study of the effects of growth hormone in experimental fracture healing. , 1980, The Journal of bone and joint surgery. British volume.
[50] J. Connolly,et al. Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs. , 1991, Clinical orthopaedics and related research.
[51] C. R. Howlett,et al. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. , 1980, Clinical orthopaedics and related research.
[52] E. Bonucci. New knowledge on the origin, function and fate of osteoclasts. , 1981, Clinical orthopaedics and related research.
[53] J G Flanagan,et al. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells , 1992, Molecular and cellular biology.
[54] K. Flanders,et al. Accumulation, localization, and compartmentation of transforming growth factor beta during endochondral bone development , 1988, The Journal of cell biology.
[55] T. Maciag,et al. The heparin-binding (fibroblast) growth factor family of proteins. , 1989, Annual review of biochemistry.
[56] C. Boehm,et al. Aspiration to Obtain Osteoblast Progenitor Cells from Human Bone Marrow: The Influence of Aspiration Volume* , 1997, The Journal of bone and joint surgery. American volume.
[57] W C Hutton,et al. The Use of an Osteoinductive Growth Factor for Lumbar Spinal Fusion: Part II Study of Dose, Carrier, and Species , 1995, Spine.
[58] J. Griffith,et al. A technique for enhancing union of allograft to host bone. , 1998, The Journal of bone and joint surgery. British volume.
[59] D T Davy,et al. Fate of vascularized and nonvascularized autografts. , 1985, Clinical orthopaedics and related research.
[60] M. Ferraro,et al. Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. , 1990, The Journal of bone and joint surgery. American volume.
[61] H. Burchardt. The biology of bone graft repair. , 1983, Clinical orthopaedics and related research.
[62] M. Klagsbrun,et al. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. , 1986, The Journal of biological chemistry.
[63] G. I. Taylor,et al. THE FREE VASCULARIZED BONE GRAFT: A Clinical Extension of Microvascular Techniques , 1975, Plastic and reconstructive surgery.
[64] H. Antoniades,et al. Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism. , 1982, Endocrinology.
[65] A. Weiland,et al. Vascularized bone autografts. Experience with 41 cases. , 1983, Clinical orthopaedics and related research.
[66] R. D. Ray. Bone grafts and bone implants. , 1972, Otolaryngologic clinics of North America.
[67] L Hangody,et al. Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete. Rationale, indications, techniques, and results. , 1999, Clinics in sports medicine.
[68] L. Peltier,et al. The Use of Plaster of Paris to Fill Defects in Bone , 1957, Annals of surgery.
[69] D. Benayahu,et al. Single‐Colony Derived Strains of Human Marrow Stromal Fibroblasts Form Bone After Transplantation In Vivo , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[70] J. Michael Kabo,et al. Evaluation of rhBMP‐2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model , 1995, Spine.
[71] H. Buncke,et al. FREE OSTEOCUTANEOUS FLAP FROM A RIB TO THE TIBIA , 1977, Plastic and reconstructive surgery.
[72] S A Goldstein,et al. Skeletal repair by in situ formation of the mineral phase of bone. , 1995, Science.
[73] A. Reddi,et al. Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects. , 1993, The Journal of clinical investigation.
[74] S. Mohan,et al. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.
[75] A. Weiler,et al. Recombinant growth hormone accelerates bone regenerate consolidation in distraction osteogenesis. , 1999, Bone.
[76] O. Isaksson,et al. Specific binding of growth hormone to isolated chondrocytes from rabbit ear and epiphyseal plate. , 1983, Endocrinology.
[77] O. Böstman,et al. Totally absorbable fixation in the treatment of fractures of the distal femoral epiphyses , 1997, Archives of Orthopaedic and Trauma Surgery.
[78] M. Kirschner,et al. The presence of fibroblast growth factor in the frog egg: its role as a natural mesoderm inducer. , 1988, Science.
[79] O. Böstman,et al. In vivo monitoring of the degradation process of bioresorbable polymeric implants using magnetic resonance imaging. , 1997, Biomaterials.
[80] K. Włodarski,et al. Properties and origin of osteoblasts. , 1990, Clinical orthopaedics and related research.
[81] T. Andreassen,et al. Dose response of growth hormone on fracture healing in the rat. , 1990, Acta orthopaedica Scandinavica.
[82] R. Derynck,et al. Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[83] K. Doi,et al. Bone grafts with microvascular anastomoses of vascular pedicles: an experimental study in dogs. , 1977, The Journal of bone and joint surgery. American volume.
[84] M. S. Clarke,et al. Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. , 1993, Journal of cell science.
[85] A. Reddi,et al. Regulation of cartilage and bone differentiation by bone morphogenetic proteins. , 1992, Current opinion in cell biology.
[86] P. Phillips,et al. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. , 1989, The Journal of biological chemistry.
[87] H. Mankin,et al. Effect of Somatomedin-C/Insulin-Like Growth Factor I and Growth Hormone on Cultured Growth Plate and Articular Chondrocytes , 1989, Pediatric Research.
[88] M Owen,et al. The origin of bone cells in the postnatal organism. , 1980, Arthritis and rheumatism.
[89] Richard A.F. Clark,et al. The Molecular and Cellular Biology of Wound Repair , 2012, Springer US.
[90] R. Marx,et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[91] M. Gebhardt,et al. Fractures of allografts. Frequency, treatment, and end-results. , 1990, The Journal of bone and joint surgery. American volume.
[92] W. Bugbee,et al. Osteochondral allograft transplantation. , 2021, Clinics in sports medicine.
[93] G. Finerman,et al. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. , 1992, Clinical orthopaedics and related research.
[94] M. Urist,et al. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. , 1988, Clinical orthopaedics and related research.
[95] J. Hollinger,et al. The integrated processes of hard tissue regeneration with special emphasis on fracture healing. , 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[96] G. Mundy,et al. Systemic Administration of Acidic Fibroblast Growth Factor (FGF‐1) Prevents Bone Loss and Increases New Bone Formation in Ovariectomized Rats , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[97] D. E. Ashhurst,et al. The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. , 1995, Bone.
[98] B. Cole,et al. Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. , 1999, Clinical orthopaedics and related research.
[99] E. Canalis. Insulin-like growth factors and osteoporosis. , 1997, Bone.
[100] S L Weissman,et al. The clinical use of combined xenografts of bone and autologous red marrow. A preliminary report. , 1978, The Journal of bone and joint surgery. British volume.
[101] R J O'Keefe,et al. The potential role of transforming growth factor beta in fracture healing. , 1998, Clinical orthopaedics and related research.
[102] G. Hofmann,et al. Allogeneic vascularized transplantation of human femoral diaphyses and total knee joints--first clinical experiences. , 1998, Transplantation proceedings.
[103] M. Maeda,et al. Continuous Administration of Basic Fibroblast Growth Factor (FGF-2) Accelerates Bone Induction on Rat Calvaria— An Application of a New Drug Delivery System , 1998, Journal of dental research.
[104] A. Ekelund,et al. Experimental induction of heterotopic bone. , 1991, Clinical orthopaedics and related research.
[105] D. Rifkin,et al. Recent developments in the cell biology of basic fibroblast growth factor , 1989, The Journal of cell biology.
[106] G. Finerman,et al. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. , 1988, Clinical orthopaedics and related research.
[107] R. Burwell. The Function of Bone Marrow in the Incorporation of a Bone Graft , 1985, Clinical orthopaedics and related research.
[108] S. Furner,et al. Musculoskeletal Conditions in the United States , 1992 .
[109] D. Gospodarowicz. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth , 1974, Nature.
[110] W. Enneking,et al. Comparative vascularization of autogenous and homogenous-bone transplants. , 1960, The Journal of bone and joint surgery. American volume.
[111] S. Cook,et al. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. , 1994, The Journal of bone and joint surgery. American volume.
[112] L. Mosekilde,et al. The effects of growth hormone on fracture healing in rats: a histological description. , 1993, Bone.
[113] I. Weissman,et al. The biology of hematopoietic stem cells. , 1995, Annual review of cell and developmental biology.
[114] S D Cook,et al. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. , 1995, The Journal of bone and joint surgery. American volume.
[115] P. Aspenberg,et al. Norian SRS versus external fixation in redisplaced distal radial fractures. A randomized study in 40 patients. , 1999, Acta orthopaedica Scandinavica.
[116] R W Jackson,et al. Percutaneous bone marrow grafting of fractures and bony defects. An experimental study in rabbits. , 1986, Clinical orthopaedics and related research.
[117] J. Poser,et al. Novel formulation of fibroblast growth factor‐2 in a hyaluronan gel accelerates fracture healing in nonhuman primates , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[118] J. Poser,et al. Potential Role of Fibroblast Growth Factor in Enhancement of Fracture Healing , 1998, Clinical orthopaedics and related research.
[119] M. Urist,et al. Bone: Formation by Autoinduction , 1965, Science.
[120] S. Singer,et al. Identification of a developmentally regulated protein-tyrosine kinase by using anti-phosphotyrosine antibodies to screen a cDNA expression library. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[121] M. Brown,et al. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). , 1989, Clinical orthopaedics and related research.
[122] Kozo Nakamura,et al. Single local injection of recombinant fibroblast growth factor‐2 stimulates healing of segmental bone defects in rabbits , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[123] C. R. Howlett,et al. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. , 1994, Bone.
[124] E. Wang,et al. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. , 1991, Archives of otolaryngology--head & neck surgery.
[125] E. Canalis,et al. Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet‐derived growth factor in osteoblast‐enriched cultures from fetal rat bone , 1991, Journal of cellular physiology.
[126] W. Enneking,et al. Observations on massive retrieved human allografts. , 1991, The Journal of bone and joint surgery. American volume.
[127] F. Melsen,et al. Transforming growth factor-beta enhances fracture healing in rabbit tibiae. , 1993, Acta orthopaedica Scandinavica.
[128] S. Cook,et al. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. , 1994, Clinical orthopaedics and related research.
[129] S. Williams,et al. Evidence for functional platelet-derived growth factor receptors on MG-63 human osteosarcoma cells. , 1984, Cancer research.
[130] H. Mankin,et al. Chondrocyte survival in cryopreserved osteochondral articular cartilage , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[131] M. Bolander,et al. Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[132] D. Sachs,et al. Use of swine model in transplantation of vascularized skeletal tissue allografts. , 1998, Transplantation proceedings.
[133] H. Mankin,et al. Osteoarticular allografts to treat distal femoral osteonecrosis. , 1994, Clinical orthopaedics and related research.
[134] S. Boden,et al. Spine update. The use of animal models to study spinal fusion. , 1994, Spine.
[135] Hiroshi Fukuda,et al. Recombinant Human Basic Fibroblast Growth Factor Accelerates Fracture Healing by Enhancing Callus Remodeling in Experimental Dog Tibial Fracture , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[136] S. Bruder,et al. Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapy , 1994 .
[137] H. Mankin,et al. Current perspectives and future directions: the 1983 Invitational Conference on Osteochondral Allografts. , 1985, Clinical orthopaedics and related research.